1. Mobile medical APP products In the past five years, Apple has been constantly telling its mobile phone users, no matter what they want to do, there will be an app to help them. This trend will become a reality for doctors and patients. As of July this year, the total number of apps in the Apple Store and Google Play has exceeded 1.5 billion, and less than 2% of them are related to medical care . The FDA issued a mobile health-related regulatory framework in September this year, which provides good legal guidance for the development of mobile medical apps. At present, not only the traditional mobile giants such as Google, Apple, Microsoft, and Alibaba are involved in the mobile medical field, but more and more startups are constantly innovating in this field. 2. Drug eluting balloon In October 2009, cardiologists Waksman and Prakala of the Washington Hospital Center speculated that the drug-eluting balloon could make a balloon catheter for percutaneous coronary intervention, and the amount of use would rise again. Their current seems to be coming true. In October of this year, Bard's Lutonix 035 product became the first drug-eluting balloon approved by the FDA. Many other companies are currently anxiously awaiting FDA approval for their drug-eluting balloon products. Medtronic's IN.PACT Admiral drug-eluting balloon is scheduled to be approved by the FDA in 2015. With the first drug-eluting balloon approved for FDA approval, the drug-eluting balloon will be a very important product and is expected to double the global balloon market in the next few years. 3. Ultrasound Focus Technology Products Imagine what would happen if a brain tumor removal procedure requires only some sedatives without having to stay in the hospital. This is the change that ultrasound focusing technology will bring to us. This technology combines real-time magnetic resonance imaging and ultrasound transducers to non-invasively remove tumors. The Israeli company Insightec's equipment has been approved by the FDA for the treatment of bone cancer and uterine fibroids. The future is expected to extend the treatment to Parkinson's syndrome, hypertension, tubal pregnancy, epilepsy, Alzheimer's disease, obesity and other fields. This year, the company has established an ultrasound focused treatment center in China and received $50 million in financing. 4. Next Generation Sequencing Technology Products Illumina, LifeTechnologies and Roche have long dominated the genetic sequencing market. But now the competition is getting worse. In the past year, nearly 10 companies have entered the field. This year's M&A activity in this area is also very active. 5. Absorbable blood vessel stent The medical device industry has been conducting many years of potential advantages and exploration of absorbable vascular stents. However, this technology is currently not used by the FDA and is used in the United States. However, this will change soon. In April of this year, Abbott has completed three recruitments for clinical trials of absorbable vascular stents in the United States, Japan, and China. Abbott’s absorbable vascular stents have been CE certified in 2011 and are currently used in more than 60 countries. In May of this year, Elixir Medical's DESolve 100 absorbable vascular stent was also licensed for CE and put into the market. It is estimated that by 2020, the global market for absorbable vascular stents will reach $1 billion. Shandong Longze Mechanical Equipment Co.,Ltd , https://www.pelletmachinefactory.com
5 medical devices worthy of attention next year